Edwards Lifesciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
25.8323.7920.2518.24
Price/Sales ratio
6.956.345.775.33
Earnings per Share (EPS)
$3.10$3.37$3.96$4.39

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
16.7234.3935.0438.2144.3646.4168.9853.7230.3432.9833.1046.41
Price/Sales ratio
5.846.826.736.918.6011.1712.9415.438.587.709.368.60
Price/Book Value ratio
6.196.797.627.9310.2011.7112.4113.837.956.958.6711.71
Price/Cash Flow ratio
13.2730.9628.3323.7534.5741.2053.8746.6137.9151.6441.3534.57
Price/Free Cash Flow ratio
14.6038.4040.9828.8046.7753.9387.7857.5848.4473.4851.7446.77
Price/Earnings Growth ratio
0.14-0.872.243.772.551.00-3.210.6514.62-5.4016.172.55
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
73.06%75.24%73.09%74.52%74.76%74.36%75.36%76.13%79.92%77.02%79.92%74.76%
Operating Profit Margin
20.77%25.77%26.44%29.77%20.09%26.37%37.12%25.77%32.48%25.54%32.48%20.09%
Pretax Profit Margin
49.24%24.95%24.89%30.12%20.45%26.82%20.89%32.52%32.83%26.61%32.83%20.45%
Net Profit Margin
34.91%19.84%19.21%18.10%19.39%24.07%18.77%28.72%28.27%23.35%28.27%19.39%
Effective Tax Rate
29.09%20.48%22.82%39.88%5.14%10.25%10.17%11.68%13.89%12.43%13.89%5.14%
Return on Assets
23.01%12.19%12.62%10.92%13.56%16.13%11.37%17.67%18.35%14.97%18.35%13.56%
Return On Equity
37.01%19.77%21.74%20.77%22.99%25.23%18.00%25.75%26.20%21.08%25.56%22.99%
Return on Capital Employed
15.61%17.93%19.70%23.79%16.82%20.53%25.67%18.05%24.05%18.78%24.05%16.82%
Liquidity Ratios
Current Ratio
5.284.304.201.802.603.303.45N/AN/AN/A3.022.60
Quick Ratio
4.593.583.461.411.912.592.562.372.172.391.872.59
Cash ratio
1.501.501.740.580.811.301.320.830.750.950.751.30
Days of Sales Outstanding
51.0646.1651.0650.9252.6750.2950.1646.3847.4050.8747.4050.29
Days of Inventory outstanding
173.16201.01181.53231.39235.84209.91270.99212.38295.77309.02295.77235.84
Operating Cycle
224.23247.17232.59282.31288.52260.20321.15258.76343.18359.89307.46288.52
Days of Payables Outstanding
33.9537.7844.4448.6252.0659.0866.3759.7668.2053.2768.2052.06
Cash Conversion Cycle
190.27209.38188.15233.69236.46201.12254.78198.99274.97306.6152.13201.12
Debt Ratios
Debt Ratio
0.160.140.180.180.110.090.080.070.070.060.290.11
Debt Equity Ratio
0.270.230.310.340.180.140.130.100.100.090.420.18
Long-term Debt to Capitalization
0.210.190.230.120.150.120.110.090.090.080.100.12
Total Debt to Capitalization
0.210.190.230.250.150.130.110.090.090.080.100.13
Interest Coverage Ratio
28.0537.3640.8244.0835.8759.8483.32N/AN/AN/A107.2635.87
Cash Flow to Debt Ratio
1.700.920.850.961.561.901.692.781.951.441.761.56
Company Equity Multiplier
1.601.621.721.901.691.561.581.451.421.401.421.56
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.440.220.230.290.240.270.240.330.220.140.220.27
Free Cash Flow / Operating Cash Flow Ratio
0.900.800.690.820.730.760.610.800.780.700.790.73
Cash Flow Coverage Ratio
1.700.920.850.961.561.901.692.781.951.441.761.56
Short Term Coverage Ratio
N/AN/AN/A1.67N/A46.2538.7667.9247.7735.9747.7746.25
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A